RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Currency in ILS

Valuation Measures

Market Cap (intraday) 5402.33M
Enterprise Value 3366.7M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)100.41
Price/Book (mrq)889.15
Enterprise Value/Revenue 391.52
Enterprise Value/EBITDA 6-7.18

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-1,275.94%

Management Effectiveness

Return on Assets (ttm)-48.58%
Return on Equity (ttm)-84.52%

Income Statement

Revenue (ttm)4.01M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)1,901.00%
Gross Profit (ttm)1.88M
EBITDA -51.05M
Net Income Avi to Common (ttm)-45.54M
Diluted EPS (ttm)-0.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.2M
Total Cash Per Share (mrq)0.22
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.37
Book Value Per Share (mrq)0.21

Cash Flow Statement

Operating Cash Flow (ttm)-44.77M
Levered Free Cash Flow (ttm)-28.2M

Trading Information

Stock Price History

Beta 0.34
52-Week Change 34,944.34%
S&P500 52-Week Change 312.90%
52 Week High 3212.00
52 Week Low 31.57
50-Day Moving Average 368.99
200-Day Moving Average 318.80

Share Statistics

Avg Vol (3 month) 3258.52k
Avg Vol (10 day) 3126k
Shares Outstanding 5213.44M
Float 182.52M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A